These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8282615)
21. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors. Cecchi A; Hulikova A; Pastorek J; Pastoreková S; Scozzafava A; Winum JY; Montero JL; Supuran CT J Med Chem; 2005 Jul; 48(15):4834-41. PubMed ID: 16033263 [TBL] [Abstract][Full Text] [Related]
22. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes. Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204 [TBL] [Abstract][Full Text] [Related]
23. Carbonic anhydrase in the membrane of the endoplasmic reticulum of male rat liver. Ono Y; Ridderstråle Y; Forster RE; Chu ZG; Dodgson SJ Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11721-5. PubMed ID: 1465389 [TBL] [Abstract][Full Text] [Related]
24. Carbonic anhydrase is not a relevant nitrite reductase or nitrous anhydrase in the lung. Pickerodt PA; Kronfeldt S; Russ M; Gonzalez-Lopez A; Lother P; Steiner E; Vorbrodt K; Busch T; Boemke W; Francis RCE; Swenson ER J Physiol; 2019 Feb; 597(4):1045-1058. PubMed ID: 29660141 [TBL] [Abstract][Full Text] [Related]
25. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design. Lehtonen JM; Parkkila S; Vullo D; Casini A; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2004 Jul; 14(14):3757-62. PubMed ID: 15203157 [TBL] [Abstract][Full Text] [Related]
26. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds. Puccetti L; Fasolis G; Cecchi A; Winum JY; Gamberi A; Montero JL; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2005 May; 15(9):2359-64. PubMed ID: 15837325 [TBL] [Abstract][Full Text] [Related]
27. Carbonic anhydrases and mucosal vanilloid receptors help mediate the hyperemic response to luminal CO2 in rat duodenum. Akiba Y; Ghayouri S; Takeuchi T; Mizumori M; Guth PH; Engel E; Swenson ER; Kaunitz JD Gastroenterology; 2006 Jul; 131(1):142-52. PubMed ID: 16831598 [TBL] [Abstract][Full Text] [Related]
28. Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors. Nishimori I; Minakuchi T; Onishi S; Vullo D; Scozzafava A; Supuran CT J Med Chem; 2007 Jan; 50(2):381-8. PubMed ID: 17228881 [TBL] [Abstract][Full Text] [Related]
29. Sulfonamide inhibition studies of the δ-carbonic anhydrase from the diatom Thalassiosira weissflogii. Vullo D; Del Prete S; Osman SM; De Luca V; Scozzafava A; Alothman Z; Supuran CT; Capasso C Bioorg Med Chem Lett; 2014 Jan; 24(1):275-9. PubMed ID: 24314394 [TBL] [Abstract][Full Text] [Related]
31. Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori. Nishimori I; Vullo D; Minakuchi T; Morimoto K; Onishi S; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2006 Apr; 16(8):2182-8. PubMed ID: 16459077 [TBL] [Abstract][Full Text] [Related]
32. Chemical properties of carbonic anhydrase IV, the membrane-bound enzyme. Maren TH; Wynns GC; Wistrand PJ Mol Pharmacol; 1993 Oct; 44(4):901-5. PubMed ID: 8232240 [TBL] [Abstract][Full Text] [Related]
33. The effect of temperature on the binding of sulfonamides to carbonic anhydrase isoenzymes I, II, and IV. Conroy CW; Maren TH Mol Pharmacol; 1995 Sep; 48(3):486-91. PubMed ID: 7565629 [TBL] [Abstract][Full Text] [Related]
34. Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II. Di Fiore A; De Simone G; Menchise V; Pedone C; Casini A; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2005 Apr; 15(7):1937-42. PubMed ID: 15780637 [TBL] [Abstract][Full Text] [Related]
35. Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis. Nishimori I; Minakuchi T; Vullo D; Scozzafava A; Innocenti A; Supuran CT J Med Chem; 2009 May; 52(9):3116-20. PubMed ID: 19338333 [TBL] [Abstract][Full Text] [Related]
36. Heterocyclic compounds as carbonic anhydrase inhibitor. Husain A; Madhesia D J Enzyme Inhib Med Chem; 2012 Dec; 27(6):773-83. PubMed ID: 21981003 [TBL] [Abstract][Full Text] [Related]
38. Carbonic anhydrase inhibition for the management of cerebral ischemia: in vivo evaluation of sulfonamide and coumarin inhibitors. Di Cesare Mannelli L; Micheli L; Carta F; Cozzi A; Ghelardini C; Supuran CT J Enzyme Inhib Med Chem; 2016 Dec; 31(6):894-9. PubMed ID: 26607399 [TBL] [Abstract][Full Text] [Related]
39. Development and pharmacological characterization of a modified procedure for the measurement of carbonic anhydrase activity. Landolfi C; Marchetti M; Ciocci G; Milanese C J Pharmacol Toxicol Methods; 1997 Nov; 38(3):169-72. PubMed ID: 9523771 [TBL] [Abstract][Full Text] [Related]
40. Effects of carbonic anhydrase inhibition on ventilation-perfusion matching in the dog lung. Swenson ER; Robertson HT; Hlastala MP J Clin Invest; 1993 Aug; 92(2):702-9. PubMed ID: 8349809 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]